Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
14.17
+0.40 (2.90%)
Aug 13, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Vision Care | 2.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vision Care Growth | 6.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical | 843.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Growth | 9.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals | 1.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Growth | 14.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals | 969.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 20.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Devices | 1.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Devices Growth | 8.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| OTC | 1.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| OTC Growth | 5.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Branded and Other Generics | 281.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Branded and Other Generics Growth | -5.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product | 17.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Growth | 18.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2018 |
| Vision Care Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vision Care Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Segment Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Segment Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Vision Care Segment Profit | 808.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vision Care Segment Profit Growth | 11.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Segment Profit | 44.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Segment Profit Growth | -46.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Segment Profit | 256.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Segment Profit Growth | -32.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Segment Profit | -614.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Segment Profit Growth | 12.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Amortization of Intangible Assets | -288.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Amortization of Intangible Assets Growth | -0.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Net Other Expense | -44.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Net Other Expense Growth | -8.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 44.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -8.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| U.S. and Puerto Rico | 2.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| U.S. and Puerto Rico Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total International | 2.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total International Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Vision Care Revenue Organic Change | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vision Care Revenue Organic Change Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Revenue Organic Change | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Revenue Organic Change Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Revenue Organic Change | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Revenue Organic Change Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Revenue Organic Change | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Revenue Organic Change Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vision Care Revenue Change in Constant Currency | 10.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vision Care Revenue Change in Constant Currency Growth | -31.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Revenue Change in Constant Currency | 11.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Revenue Change in Constant Currency Growth | 30.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Revenue Change in Constant Currency | 17.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Revenue Change in Constant Currency Growth | -43.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Revenue Change in Constant Currency | 45.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Revenue Change in Constant Currency Growth | -57.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|